TY - JOUR
T1 - Correction
T2 - Functional Assays Evaluating Immunosuppression Mediated by Myeloid-Derived Suppressor Cells
AU - Reuven, Or
AU - Mikula, Ivan
AU - Ashkenazi-Preiser, Hadas
AU - Twaik, Nira
AU - Ben-Meir, Kerem
AU - Meirow, Yaron
AU - Daniel, Leonor
AU - Kariv, Guy
AU - Kurd, Mahdi
AU - Baniyash, Michal
N1 - Publisher Copyright:
© 2024 Wiley Periodicals LLC.
PY - 2024/12
Y1 - 2024/12
N2 - Current Protocols is issuing corrections for the following protocol article. Reuven, O., Mikula, I., Ashkenazi-Preiser, H., Twaik, N., Ben-Meir, K., Meirow, Y., Daniel, L., Kariv, G., Kurd, M., & Baniyash, M. (2022). Functional assays evaluating immunosuppression mediated by myeloid-derived suppressor cells. Current Protocols, 2, e557. doi: 10.1002/cpz1.557 In the above-referenced article: In step 11 of Support Protocol 2, “0.03125 µg/ml” has been changed to “0.03125 mg/ml”. The current version online now includes this correction and may be considered the authoritative version of record.
AB - Current Protocols is issuing corrections for the following protocol article. Reuven, O., Mikula, I., Ashkenazi-Preiser, H., Twaik, N., Ben-Meir, K., Meirow, Y., Daniel, L., Kariv, G., Kurd, M., & Baniyash, M. (2022). Functional assays evaluating immunosuppression mediated by myeloid-derived suppressor cells. Current Protocols, 2, e557. doi: 10.1002/cpz1.557 In the above-referenced article: In step 11 of Support Protocol 2, “0.03125 µg/ml” has been changed to “0.03125 mg/ml”. The current version online now includes this correction and may be considered the authoritative version of record.
UR - http://www.scopus.com/inward/record.url?scp=85212694381&partnerID=8YFLogxK
U2 - 10.1002/cpz1.70082
DO - 10.1002/cpz1.70082
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???
C2 - 39688138
AN - SCOPUS:85212694381
SN - 2691-1299
VL - 4
JO - Current Protocols
JF - Current Protocols
IS - 12
M1 - e70082
ER -